Lecanemab
Monoclonal antibody used as Alzheimer's medication
Lecanemab ▸ Facts ▸ Comments ▸ News ▸ Videos
Lecanemab, sold under the brand name Leqembi, is a monoclonal antibody medication used for the treatment of Alzheimer's disease. Lecanemab is an amyloid beta-directed antibody. It is given via intravenous infusion.
| 0 shares | ShareTweetSavePostSend |
You Might Like
What is Alzheimer's, how common is it – and will new drug Lecanemab help patients in the UK? A new drug is making headlines around the world for being the first ever to slow the progression of Alzheimer's disease.Sky News - Published |
| Search this site and the web: |
